Clinical trials
Phase 2 Lung Diseases, Interstitial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
| Completed | 14 |
| Terminated | 10 |
| Active, not recruiting | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bastiaan Driehuys | 4 |
| Celgene | 3 |
| Mayo Clinic | 2 |
| Michael Roth | 2 |
| Novartis Pharmaceuticals | 2 |
| Pulmovant, Inc. | 2 |
| AllRock Bio, Inc. | 1 |
| Avalyn Pharma Inc. | 1 |
| Biogen | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 50 |
| Pulmonary Fibrosis | 14 |
| Scleroderma, Systemic | 12 |
| Idiopathic Pulmonary Fibrosis | 11 |
| Hypertension, Pulmonary | 9 |
| Scleroderma, Diffuse | 9 |
| Fibrosis | 8 |
| Lung Diseases | 7 |
| Pulmonary Arterial Hypertension | 5 |
| Idiopathic Interstitial Pneumonias | 4 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.